Druggable genome in attention deficit/hyperactivity disorder and
$ 37.00
-
By A Mystery Man Writer
-
-
4.5(141)
Product Description
Pharmacogenomics: The Future of ADHD Treatment Options
Frontiers Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials
Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose. - Abstract - Europe PMC
Chapter 19: ADHD and Alzheimer's Drugs – Drugs and Behavior
Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome
Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment
Systematic Review: Molecular Studies of Common Genetic Variation in Child and Adolescent Psychiatric Disorders - Journal of the American Academy of Child & Adolescent Psychiatry
Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms
